Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Benicar

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Benicar was produced by Daiichi Sankyo.

Daiichi Sankyo to shut down German antibody unit U3

Daiichi Sankyo to shut down German antibody unit U3

The restricting comes as Daiichi Sankyo faces the loss of patent protection in the US for Benicar (olmesartan), a $2.4bn-a-year product used to treat high blood pressure.

Daiichi Sankyo cuts a swathe through US workforce

Daiichi Sankyo cuts a swathe through US workforce Japan's Daiichi Sankyo is planning to the slash the size of its US workforce as it contends with the loss of patent protection for top-selling drug Benicar. ... The company will need late-stage pipeline candidates to deliver if it is to ride out the

Daiichi Sankyo pays $39m in whistleblower case

Daiichi Sankyo pays $39m in whistleblower case several of its products, including high blood pressure treatment Benicar (olmesartan) and various combinations of the drug with other antihypertensive agents.

Takeda launches Azilva for blood pressure in Japan

Daiichi Sankyo's Benicar/Olmetec (olmesartan).

Result pages: 1 | 2 | 3 | 4 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics